Genecast offers DNA testing of tumors and gene-based medicine guidance. The company claims expertise in lung, colon, liver and breast cancers. Genecast plans to use the proceeds for further research and clinical trials, as well as expanding distribution channels.
Crunchbase Investment Rounds
|Date||Amount||Round||Valuation||Lead Investor||Other Investors|
|2018-02-27||$33,000,000||Series C||Loyal Valley Capital, Matrix Partners China||Yahui Precision Medicine Fund, Cowin Venture|
|2017-02-10||$18,000,000||Series B||Tsinghua Holdings|